VEGFA and diabetes mellitus: Hyperglycemia and increased AGEs in diabetes cause defective VEGF signaling including inactivation of the VEGF receptor, FLK-1, which affects endothelial growth and migration, monocyte, and EPC recruitment and release from bone marrow.